A comparative study of T-cell depleted and non-depleted marrow transplantation for hematological malignancy.
暂无分享,去创建一个
J. Biggs | K. Atkinson | A. Dodds | A. Concannon | M. Ashby | M. Cooley | G. Morgan | E. O'Flaherty | H. Farrelly | H. Raphael | E. O'flaherty | Kerry Atkinson | Anthony J. Dodds | Margaret A. Cooley | Graeme Morgan | I. F. C. MckENZIE
[1] J. Biggs,et al. The impact of leukemia status at the time of HLA-identical sibling marrow transplantation on subsequent complication rate and survival of adults with acute leukemia. , 1986, Australian and New Zealand journal of medicine.
[2] J. Biggs,et al. Female marrow donors increase the risk of acute graft‐versus‐host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum , 1986, British journal of haematology.
[3] K. Atkinson,et al. Practical aspects of T cell depletion of bone marrow for clinical marrow allografting. , 1986, Transplantation Proceedings.
[4] H. Deeg,et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.
[5] J. Biggs,et al. Towards safer bone‐marrow transplantation , 1986, The Medical journal of Australia.
[6] H. Deeg,et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts , 1985 .
[7] E. Gordon-Smith,et al. Cyclosporine and graft failure following bone marrow transplantation for severe aplastic anaemia , 1985, British journal of haematology.
[8] Kennedy,et al. Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. , 1985, Blood.
[9] E. Brown,et al. Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. , 1985, Science.
[10] P. Hogarth,et al. Ly Antigens Associated with T Cell Recognition and Effector Function , 1984, Immunological reviews.
[11] G. Hale,et al. ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1) , 1984, The Lancet.
[12] G. Janossy,et al. DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTS , 1984, The Lancet.
[13] J. Biggs,et al. Cyclosporine-associated central-nervous-system toxicity after allogeneic bone-marrow transplantation. , 1984, The New England journal of medicine.
[14] J. Biggs,et al. Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: implications of clinical gut dysfunction , 1984, British journal of haematology.
[15] J. Kemshead,et al. REMOVAL OF NEUROBLASTOMA CELLS FROM BONE MARROW WITH MONOCLONAL ANTIBODIES CONJUGATED TO MAGNETIC MICROSPHERES , 1984, The Lancet.
[16] K. Atkinson,et al. The chemical and immunosuppressive stability of cyclosporine during continuous intravenous infusion. , 1983, Transplantation.
[17] J. Dausset,et al. Behavior of HLA-compatible and incompatible skin allografts in human recipients preimmunized with pooled leukocyte extracts obtained from randomly selected donors. , 1983, Transplantation.
[18] A. D'apice,et al. A monoclonal anti-pan-T-cell antibody. In vitro and in vivo studies. , 1983, Transplantation.
[19] R. Hopkins,et al. A rapid, large scale purification procedure for gibbon interleukin 2. , 1983, Journal of immunology.
[20] K. Atkinson,et al. Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes , 1983, British journal of haematology.
[21] L. Robison,et al. A randomized study of the prevention of acute graft-versus-host disease. , 1982, The New England journal of medicine.
[22] K. Sullivan,et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.
[23] J. Sprent,et al. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow , 1978, The Journal of experimental medicine.
[24] R Storb,et al. Bone-marrow transplantation (first of two parts). , 1975, The New England journal of medicine.
[25] R. Storb,et al. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. , 1974, Transplantation proceedings.
[26] P. Neiman,et al. CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.
[27] R Storb,et al. Technique for human marrow grafting. , 1970, Blood.
[28] Hildemann Wh. Transplantation immunity in fishes: Agnatha, Chondrichthyes and Osteichthyes. , 1970 .
[29] S. Zail,et al. Effect of ethanol on liver 8-aminolaevulinate synthetase in rats. , 1968 .
[30] Williams Ja. SKIN LESIONS AS RESERVOIRS OF HOSPITAL INFECTION. , 1965 .
[31] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .